PMID: 7521259Jun 1, 1994Paper

Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation

British Journal of Pharmacology
A KawabataH Takagi

Abstract

1. We investigated the effects of intraplantar (i.pl.) administration of L-arginine and NG-nitro-L-arginine methyl ester (L-NAME) on formalin-induced behavioural nociception in the mouse. 2. L- but not D-arginine, at 0.1-1 microgram per paw, coadministered with i.pl. formalin, enhanced the second-but not the first-phase nociceptive responses, whereas it was without significant effects at 3 micrograms per paw, and conversely, produced antinociception at 10 micrograms per paw, resulting in a bell-shaped dose-response curve. 3. L-NAME at 0.1-1 microgram per paw, when administered i.pl., exhibited antinociceptive activity in the second phase in a dose-dependent manner, although its D-enantiomer produced no effect. 4. An antinociceptive dose (1 microgram per paw) of L-NAME (i.pl.) considerably reduced the increase in second-phase nociception elicited by low doses (1 microgram per paw) of i.pl. L-arginine. The second-phase nociception decrease induced by a large dose (10 micrograms per paw) of i.pl. L-arginine was markedly reversed by i.pl. L-NAME at 0.1 micrograms per paw, raising it to a level above that of the control (formalin only). 5. These results suggest that peripheral NO plays a dual role in nociceptive modulation, dependin...Continue Reading

References

Dec 1, 1992·Toxicology Letters·A P CorradoG de Nucci
Dec 7, 1992·Neuroscience Letters·N J DunL F Tseng
Dec 14, 1992·Neuroscience Letters·K F KittoG L Wilcox
Dec 14, 1992·Neuroscience Letters·J G ValtschanoffH H Schmidt
Jan 1, 1992·Neuron·D S Bredt, S H Snyder
Mar 1, 1992·Trends in Neurosciences·S R Vincent, B T Hope
Jul 7, 1992·European Journal of Pharmacology·S H FerreiraL H Faccioli
Feb 11, 1992·European Journal of Pharmacology·A IalentiM Di Rosa
Dec 4, 1990·European Journal of Pharmacology·S R HughesS D Brain
Sep 21, 1990·European Journal of Pharmacology·I D DurateS H Ferreira
Jan 1, 1991·British Journal of Pharmacology·P K MooreS L Hart
Feb 1, 1993·Pain·S T Meller, G F Gebhart

❮ Previous
Next ❯

Citations

Oct 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·D J Tracey, J S Walker
Mar 30, 1999·Biulleten' eksperimental'noĭ biologii i meditsiny·E I DanilovaV A Zinkevich
Sep 15, 1996·Journal of the Neurological Sciences·S ShibutaI Yoshiya
Jan 28, 2004·European Journal of Pharmacology·Ken-ichiro HayashidaEtsumori Harada
Jan 28, 2004·European Journal of Pharmacology·Myrna Déciga-Campos, Francisco J López-Muñoz
Jul 29, 2000·European Journal of Pharmacology·T Mixcoatl-ZecuatlV Granados-Soto
May 15, 2002·European Journal of Pharmacology·Wiliam A PradoFernando Q Cunha
Jun 23, 2001·Pharmacology, Biochemistry, and Behavior·A Onal, N Soykan
Oct 12, 2002·Pharmacology, Biochemistry, and Behavior·Marcela B EcheverryElaine A Del Bel
Sep 19, 2003·Pharmacology, Biochemistry, and Behavior·Mario I OrtizGilberto Castañeda-Hernández
Feb 13, 1999·Progress in Neurobiology·M J Millan
Nov 5, 1997·Journal of Pain and Symptom Management·M Anbar, B M Gratt
Aug 5, 2000·Journal of Pharmacological and Toxicological Methods·M Islas-CadenaV Granados-Soto
Sep 29, 1998·The European Journal of Neuroscience·D Levy, D W Zochodne
May 1, 2009·Spine·Shigeru KobayashiHisatoshi Baba
Nov 1, 1995·British Journal of Pharmacology·P HolzerB A Peskar
Jan 1, 1996·British Journal of Pharmacology·A Kawabata
Dec 1, 1996·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·B L LopezX Ma
May 20, 1999·Annual Review of Pharmacology and Toxicology·A J HobbsS Moncada
Nov 11, 2005·Inflammopharmacology·Chandrashekhar S PatilShrinivas K Kulkarni
Jul 16, 2005·Expert Opinion on Biological Therapy·Stephen C PryorGeorge B Stefano
Aug 1, 1996·Chest·T Mizutani, A J Layon
Jun 19, 2010·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Mahmoud HosseiniHojjat Allah Alaei
Aug 21, 2007·Journal of Ethnopharmacology·A O AzevedoA C Perez
Aug 26, 2009·Acta Anaesthesiologica Scandinavica·A Miclescu, T Gordh
Apr 25, 2003·British Journal of Pharmacology·Gustavo G VivancosSérgio H Ferreira
Oct 22, 2004·European Journal of Pharmacology·Rosa Ventura-MartínezFrancisco J López-Muñoz
Apr 25, 2006·Pharmacology, Biochemistry, and Behavior·Mario I OrtizVinicio Granados-Soto
Jan 3, 2006·Pharmacology, Biochemistry, and Behavior·Mario I OrtizGilberto Castañeda-Hernández
Dec 29, 2005·Brain Research·Tomohito TsuchiyaEtsumori Harada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.